MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0014416
Raush Pharmaceuticals Private Limited
Raush Pharmaceuticals Private Limited - trading in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.79 Lakh
▼ 11% YoY
Net profit · FY 2025
₹8,939
Net margin 0.4%
EBITDA · FY 2025
₹66,480
EBITDA margin 2.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Raush Pharmaceuticals Private Limited
Data last updated:
Raush Pharmaceuticals Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24100HR2011PTC043333. Its GSTIN is 06AAFCR4285E1ZD (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suresh Sharma and Sandeep Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 48 Ward No. 19 Sham Nagar Babyal, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.79 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹8,939 (net margin 0.4%) and EBITDA of ₹66,480 (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Raush Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0014416). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100HR2011PTC043333
Registration Number 043333
Incorporation Date 01 July 2011
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0014416
Key People
Suresh Sharma Director Sandeep Sharma Director Recognitions & Rankings of Raush Pharmaceuticals
Contact details
Raush Pharmaceuticals Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 48 Ward No. 19 Sham Nagar Babyal, Ambala Cantt, Haryana, India – 133001
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Raush Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Raush Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Raush Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Raush Pharmaceuticals Private Limited, buy the company report.
Financials of Raush Pharmaceuticals Private Limited
FY 2025 filings availableRaush Pharmaceuticals Private Limited reported revenue of ₹24.79 Lakh (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹24.79 Lakh ▼ 11%
Net profit · FY 2025
₹8,939 margin 0.4%
EBITDA · FY 2025
₹66,480 margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 14%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 21%
5 years · compounded
▼ 26%
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 11% fall in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66,480 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,939 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raush Pharmaceuticals Private Limited, buy the company report.
Board of directors of Raush Pharmaceuticals Private Limited
Raush Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Sharma Also directs: Biotric Healthcare Private Limited | Director | 11 Jan 2016 | 10 Years 9 Months | Current |
| Sandeep Sharma | Director | 01 Jul 2011 | 15 Years 3 Months | Current |
Peer comparison
Raush Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salutem Pharmaceuticals Private Limited | ₹24.85 Lakh (FY 2025) | 4.0% | Jammu, Jammu and Kashmir, India | |||
| Byprio Pharmaceuticals Private Limited | ₹24.84 Lakh (FY 2025) | 54.0% | Pune, Maharashtra, India | |||
| Bright Health Pharmaceuticals Private Limited | ₹24.83 Lakh (FY 2025) | 58.0% | Bareilly, Uttar Pradesh, India | |||
| Raush Pharmaceuticals Private Limitedthis company | ₹24.79 Lakh (FY 2025) | ₹8,939 | 0.4% | -11.0% | Ambala Cantt, Haryana, India | |
| Biostone Pharmaceuticals Private Limited | ₹24.71 Lakh (FY 2025) | 16.0% | Delhi, India |
To see the full peer comparison of Raush Pharmaceuticals Private Limited, buy the company report.
Auditor
Raush Pharmaceuticals Private Limited is audited by GNRA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GNRA & CO | FY 2017 | 019674N |
Shareholding
The shareholding of Raush Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Raush Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2014 | 10527227 | Indian Overseas Bank | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raush Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raush Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raush Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCR4285E1ZD | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Raush Pharmaceuticals Private Limited, buy the company report.
Recent activity
Raush Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Rajdulari ceased to be Director on 20 Jan 2016.
AGM
Raush Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raush Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Rajdulari ceased to be Director.
Appointed
Suresh Sharma was appointed as Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 20.00 Lakh with Charge ID 10527227 was registered on 08 Aug 2014.
Ceased
Sanjeevan Lata ceased to be Director.
Appointed
Sandeep Sharma was appointed as Director.
Incorporation
01 Jul 2011
Raush Pharmaceuticals Private Limited was registered on 01 Jul 2011 with Roc Haryana & aged 15 years 3 months as per MCA records.
Frequently asked questions
Raush Pharmaceuticals is an active private limited company based in Ambala Cantt, Haryana, India. The company works in wholesale, within the trading industry. It was incorporated on 01 July 2011 (15+ years old) and is registered under CIN U24100HR2011PTC043333.
Raush Pharmaceuticals has 2 current directors:
- Suresh Sharma - Director
- Sandeep Sharma - Director
The latest financial statements of Raush Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Raush Pharmaceuticals is 06AAFCR4285E1ZD, registered in Haryana.
The CIN (Corporate Identification Number) of Raush Pharmaceuticals is U24100HR2011PTC043333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raush Pharmaceuticals was incorporated on 01 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Raush Pharmaceuticals by revenue are Salutem Pharmaceuticals Private Limited, Byprio Pharmaceuticals Private Limited, Bright Health Pharmaceuticals Private Limited, Biostone Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajdulari ceased to be Director on 20 Jan 2016. Suresh Sharma was appointed as Director on 11 Jan 2016. Sanjeevan Lata ceased to be Director on 22 Apr 2012. Raush Pharmaceuticals has 4 board changes on record in total.
Yes, Raush Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0014416).
The registered office of Raush Pharmaceuticals is at House No. 48 Ward No. 19 Sham Nagar Babyal, Ambala Cantt, Haryana, India – 133001.
Raush Pharmaceuticals operates in the trading industry, in the wholesale segment.